EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Bloom's Syndrome: Clinical Spectrum, Molecular Pathogenesis, and Cancer Predisposition

Christopher Cunniff, Jennifer A Bassetti, Nathan A Ellis

Molecular Syndromology · 2017 · 8 (1) · 4-23

DOI: 10.1159/000452082 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Syndromology, online erschienen am 05.11.2016. Verfasst von Christopher Cunniff und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Genetics, Department of Pediatrics, Weill Cornell Medical College, New York, N.Y, USA. Die Arbeit wurde bisher 270-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bloom's syndrome is an autosomal recessive disorder characterized by prenatal and postnatal growth deficiency, photosensitive skin changes, immune deficiency, insulin resistance, and a greatly increased risk of early onset of cancer and for the development of multiple cancers. Loss-of-function mutations of BLM, which codes for a RecQ helicase, cause Bloom's syndrome. The absence of a functional BLM protein causes chromosome instability, excessive homologous recombination, and a greatly increased number of sister chromatid exchanges that are pathognomonic of the syndrome. A common founder mutation designated blmAsh is present in about 1 in 100 persons of Eastern European Jewish ancestry, and there are additional recurrent founder mutations among other populations. Missense, nonsense, and frameshift mutations as well as multiexonic deletions have all been observed. Bloom's syndrome is a prototypical chromosomal instability syndrome, and the somatic mutations that occur as a result of that instability are responsible for the increased cancer risk. Although there is currently no treatment aimed at the underlying genetic abnormality, persons with Bloom's syndrome benefit from sun protection, aggressive treatment of infections, surveillance for insulin resistance, and early identification of cancer.

Schlagwörter

Stichwörter der Autor:innen

BLMBloom's syndromeCancer

Autor:innen und Institutionen

  • Division of Medical Genetics, Department of Pediatrics, Weill Cornell Medical College, New York, N.Y, USA.
  • Department of Cellular and Molecular Medicine, University of Arizona Cancer Center, Tucson, Ariz., USA.

Förderung

  • NCI NIH HHS
  • NCATS NIH HHS

Zitieren

APA

Cunniff, C., Bassetti, J. A., & Ellis, N. A. (2017). Bloom's Syndrome: Clinical Spectrum, Molecular Pathogenesis, and Cancer Predisposition. Molecular Syndromology, 8(1), 4-23. https://doi.org/10.1159/000452082

Vancouver

Cunniff C, Bassetti JA, Ellis NA. Bloom's Syndrome: Clinical Spectrum, Molecular Pathogenesis, and Cancer Predisposition. Molecular Syndromology. 2017;8(1):4-23. doi:10.1159/000452082

BibTeX
@article{Cunniff2017,
  author = {Cunniff, Christopher and Bassetti, Jennifer A and Ellis, Nathan A},
  title = {Bloom's Syndrome: Clinical Spectrum, Molecular Pathogenesis, and Cancer Predisposition},
  journal = {Molecular Syndromology},
  year = {2017},
  volume = {8},
  number = {1},
  pages = {4--23},
  doi = {10.1159/000452082}
}
Kostenlos starten →